02/06/2026
✨ Exciting News! ✨
River City Rheumatology will be offering a GLP-1 Weight Management Program beginning in March!
This program will include compounded semaglutide and compounded tirzepatide for eligible patients following a medical evaluation and ongoing medical monitoring.
GLP-1 medications may support not only sustainable weight loss and metabolic health, but may also help reduce systemic inflammation, which can be beneficial for patients managing chronic inflammatory and autoimmune conditions.
📌 More details regarding eligibility, program structure, and pricing are now available.
📞 Interested? Please contact our office for more information.